Comparative Biosciences, Inc. (CBI), a leading preclinical Contract Research Organization (CRO), offers dermal bioavailability, ADME, pharmacokinetic and toxicokinetic studies in all species in normal and in diseased animals and with single, multiple or infusion/slow release dose administration with small molecules, biologics, stem cells, nanoparticles and devices.
Dermal pharmacokinetics or bioavailability study expertise includes:
- Dermal pharmacokinetics or bioavailability studies in rodents
- Dermal pharmacokinetics or bioavailability studies in minipigs or other nonrodent species
- Dermal pharmacokinetic and toxicokinetic studies in disease models, such as diabetes, inflammation, wound healing, or burns